Next earnings date: 4 Sep 2025
Pressure BioSciences, Inc. – OTC:PBIO
Pressure BioSciences stock price today
Pressure BioSciences stock price monthly change
Pressure BioSciences stock price quarterly change
Pressure BioSciences stock price yearly change
Pressure BioSciences key metrics
Market Cap | 24.44M |
Enterprise value | 32.30M |
P/E | -0.71 |
EV/Sales | 22.47 |
EV/EBITDA | -5.35 |
Price/Sales | 9.21 |
Price/Book | -0.44 |
PEG ratio | -0.01 |
EPS | -403.76 |
Revenue | 1.97M |
EBITDA | -9.82M |
Income | -6.40B |
Revenue Q/Q | -48.55% |
Revenue Y/Y | 14.36% |
Profit margin | -1078.21% |
Oper. margin | -318.11% |
Gross margin | 36.41% |
EBIT margin | -318.11% |
EBITDA margin | -496.91% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePressure BioSciences stock price history
Pressure BioSciences stock forecast
Pressure BioSciences financial statements
| Mar 2023 | 740.6K | -6.38B | -861468.11% |
|---|---|---|---|
| Jun 2023 | 511.80K | -6.92M | -1352.61% |
| Sep 2023 | 413.00K | -6.26M | -1516.19% |
| Dec 2023 | 312.35K | -9.90M | -3170.73% |
| Payout ratio | 0% |
|---|
| 2019 | 8255.16% |
|---|---|
| 2020 | 4278.58% |
| 2021 | 1202.02% |
| 2022 | 2687.14% |
| 2023 |
| Mar 2023 | 2213834 | 34.66M | 1565.75% |
|---|---|---|---|
| Jun 2023 | 1675756 | 26.79M | 1598.73% |
| Sep 2023 | 1602119 | 30.20M | 1885.18% |
| Dec 2023 | 1049676 | 33.80M | 3220.38% |
| Mar 2023 | -422.21K | -3K | 660.36K |
|---|---|---|---|
| Jun 2023 | -899.17K | 0 | 685.12K |
| Sep 2023 | -732.43K | -4.49K | 717.22K |
| Dec 2023 | -1.13M | 0 | 1.20M |
Pressure BioSciences alternative data
| Aug 2023 | 16 |
|---|---|
| Sep 2023 | 16 |
| Oct 2023 | 16 |
| Nov 2023 | 16 |
| Dec 2023 | 16 |
| Jan 2024 | 16 |
| Feb 2024 | 16 |
| Mar 2024 | 16 |
| Apr 2024 | 16 |
| May 2024 | 16 |
| Jun 2024 | 16 |
| Jul 2024 | 15 |
Pressure BioSciences other data
| Period | Buy | Sel |
|---|---|---|
| Sep 2021 | 95045 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | SCHUMACHER RICHARD T director, officer: President, CEO | SERIES AA CONVERTIBLE PREFERRED STOCK | 23,314 | $2.5 | $58,285 | ||
Purchase | LAZAREV ALEXANDER V officer: VP of Re.. | SERIES AA CONVERTIBLE PREFERRED STOCK | 26,486 | $2.5 | $66,215 | ||
Purchase | PETERSON JEFFREY N director | SERIES AA CONVERTIBLE PREFERRED STOCK | 45,245 | $2.5 | $113,113 | ||
Purchase | YOUNG BRADFORD ADDISON officer: Chief Commerical Officer | COMMON STOCK | 1,579 | $2.25 | $3,550 | ||
Purchase | YOUNG BRADFORD ADDISON officer: Chief Commerical Officer | COMMON STOCK | 1,579 | N/A | N/A | ||
Purchase | SCHUMACHER RICHARD T director, officer: President, CEO | COMMON STOCK | 1,500 | $1.38 | $2,066 | ||
Purchase | SCHUMACHER RICHARD T director, officer: President, CEO | COMMON STOCK | 1,500 | N/A | N/A | ||
Purchase | SCHUMACHER RICHARD T director, officer: President, CEO | COMMON STOCK | 500 | $1.1 | $548 | ||
Purchase | SCHUMACHER RICHARD T director, officer: President, CEO | COMMON STOCK | 500 | N/A | N/A | ||
Purchase | LAWRENCE NATHAN officer: VP of Marketing & Sales | COMMON STOCK | 1,000 | N/A | N/A |
| Patent |
|---|
Grant Filling date: 28 Mar 2016 Issue date: 3 Nov 2020 |
Grant Filling date: 29 May 2015 Issue date: 14 Jul 2020 |
| Quarter | Transcript |
|---|---|
| Q3 2023 21 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 22 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 16 May 2023 | Q1 2023 Earnings Call Transcript |
| Q4 2022 18 Apr 2023 | Q4 2022 Earnings Call Transcript |
-
What's the price of Pressure BioSciences stock today?
One share of Pressure BioSciences stock can currently be purchased for approximately $0.
-
When is Pressure BioSciences's next earnings date?
Pressure BioSciences, Inc. is estimated to report earnings on Thursday, 4 Sep 2025.
-
Does Pressure BioSciences pay dividends?
No, Pressure BioSciences does not pay dividends.
-
How much money does Pressure BioSciences make?
Pressure BioSciences has a market capitalization of 24.44M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14.36% to 1.98M US dollars.
-
What is Pressure BioSciences's stock symbol?
Pressure BioSciences, Inc. is traded on the OTC under the ticker symbol "PBIO".
-
What is Pressure BioSciences's primary industry?
Company operates in the Healthcare sector and Medical Devices industry.
-
How do i buy shares of Pressure BioSciences?
Shares of Pressure BioSciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Pressure BioSciences's key executives?
Pressure BioSciences's management team includes the following people:
- Mr. Richard T. Schumacher Founder, Pres, Chief Executive Officer, Treasurer, Interim Chief Financial Officer, Clerk & Director(age: 75, pay: $332,800)
- Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D. Senior Vice President of Engineering(age: 70, pay: $218,750)
- Dr. Alexander V. Lazarev Chief Science Officer(age: 60, pay: $214,250)
-
Is Pressure BioSciences founder-led company?
Yes, Pressure BioSciences is a company led by its founder Mr. Richard T. Schumacher.
-
How many employees does Pressure BioSciences have?
As Jul 2024, Pressure BioSciences employs 15 workers, which is 6% less then previous month and 6% less then previous quarter.
-
When Pressure BioSciences went public?
Pressure BioSciences, Inc. is publicly traded company for more then 28 years since IPO on 31 Oct 1996.
-
What is Pressure BioSciences's official website?
The official website for Pressure BioSciences is pressurebiosciences.com.
-
Where are Pressure BioSciences's headquarters?
Pressure BioSciences is headquartered at 14 Norfolk Ave, South Easton, MASSACHUSETTS.
-
How can i contact Pressure BioSciences?
Pressure BioSciences's mailing address is 14 Norfolk Ave, South Easton, MASSACHUSETTS and company can be reached via phone at +1 508 230 1828.
Pressure BioSciences company profile:
Pressure BioSciences, Inc.
pressurebiosciences.comOTC
12
Medical Devices
Healthcare
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp.
South Easton, MASSACHUSETTS 02375
CIK: 0000830656
ISIN: US74112E2081
CUSIP: 74112E208
